Neurogene Inc. (NASDAQ: NGNE)
$45.74
-0.2100 ( -0.46% ) 90.0K
Neurogene Inc is a clinical stage biotechnology company whose objective is to harness the power of gene therapy which is combined with its EXACT gene regulation technology to turn today's complex devastating neurological diseases into treatable conditions.
Market Data
Open
$45.74
Previous close
$45.95
Volume
90.0K
Market cap
$593.85M
Day range
$44.25 - $47.31
52 week range
$12.49 - $53.00
SEC Fillings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 10-q | Quarterly Reports | 80 | May 10, 2024 |
| 8-k | 8K-related | 15 | May 07, 2024 |
| ars | Annual reports | 1 | Apr 26, 2024 |
| def | Proxies and info statements | 22 | Apr 26, 2024 |
| 8-k | 8K-related | 13 | Apr 25, 2024 |
| 8-k | 8K-related | 15 | Apr 22, 2024 |
| 8-k | 8K-related | 13 | Apr 02, 2024 |
| 8-k | 8K-related | 15 | Mar 18, 2024 |
| 10-k | Annual reports | 121 | Mar 18, 2024 |
| 4 | Insider transactions | 1 | Mar 14, 2024 |